comparemela.com

Latest Breaking News On - Mc services - Page 6 : comparemela.com

ViGeneron Announces First Patient Dosed in Phase 1b Clinical Trial of VG901 for the Intravitreal Treatment of Retinitis Pigmentosa

VG901 is the first and only clinical-stage therapy designed to deliver a functional CNGA1 gene to retinal photoreceptor target cells in retinitis .

United-states
Germany
Munich
Bayern
Vigeneron-gmb
Katarina-stingl
Shaun-brown-julia
Mc-services
Orphan-drug-designation
Generon-gmbh
Hereditary-retinal-degenerations
Rare-eye-diseases

AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock

With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden .

Hennigsdorf
Brandenburg
Germany
Berlin
Belgium
Nijmegen
Gelderland
Netherlands
Brussels
Bruxelles-capitale
Geneva
Genè

Mainz Biomed Reports Full Year 2023 Financial Results

Issuer: Mainz BioMed N.V. / Key word: Annual Results Mainz Biomed Reports Full Year 2023 Financial Results 09.04.2024 / 14:01 CET/CEST The issuer is solely responsible.

Germany
Berkeley
California
United-states
Portugal
Spain
United-kingdom
Israel
Romania
Poland
Hershel-berry
Anne-hennecke-caroline-bergmann

EQS-News: Mainz Biomed Reports Full Year 2023 Financial Results

Issuer: Mainz Biomed N.V. / Key word(s): Annual Results Mainz Biomed Reports Full Year 2023 Financial Results 09.04.2.

Poland
Romania
Portugal
Israel
Spain
Germany
Berkeley
California
United-states
United-kingdom
Guido-baechler
Jay-wohlgemuth

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) -April 08, 2024 at 01:02 am EDT

EQS-News: Newron Pharmaceuticals S.p.A. / Key word: Study results Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual.

Israel
Australia
Canada
Bresso
Lombardia
Italy
Germany
Milan
Switzerland
Seika
Kyongsang-bukto
South-korea

vimarsana © 2020. All Rights Reserved.